Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy

European Urology

Volumn 66, Issue 3, 2014, Pages 479-486

  Briganti, Alberto ^a   Karnes, R Jeffrey ^b   Joniau, Steven ^c   Boorjian, Stephen A ^b   Cozzarini, Cesare ^a   Gandaglia, Giorgio ^a,d   Hinkelbein, Wolfgang ^e   Haustermans, Karin ^c   Tombal, Bertrand ^f   Shariat, Shahrokh ^g   Sun, Maxine ^d   Karakiewicz, Pierre I ^d   Montorsi, Francesco ^a   Van Poppel, Hein ^c   Wiegel, Thomas ^h  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b MAYO CLINIC   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

^h UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Biochemical recurrence; Nomogram; Prostate cancer; Radical prostatectomy; Salvage radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLOOD; CANCER GRADING; CANCER STAGING; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY; NEOPLASM RECURRENCE, LOCAL; NOMOGRAM; PATHOLOGY; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL RATE; VALIDATION STUDY;

DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; NOMOGRAMS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE;

EID: 84905905679     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.11.045     Document Type: Article

References (32)

1. J.K. Mullins, Z. Feng, and B.J. Trock et al. The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary J Urol 188 2012 2219 2224
2. S.A. Boorjian, J.A. Eastham, and M. Graefen et al. A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes Eur Urol 61 2012 664 675
3. C.R. Pound, A.W. Partin, and M.A. Eisenberger et al. Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
4. S.J. Freedland, E.B. Humphreys, and L.A. Mangoid et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 94 2005 433 439
5. N. Mottet, J. Bellmunt, and M. Bolla et al. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer Eur Urol 59 2011 572 583
6. I.M. Thompson, R.K. Valicenti, and P. Albertsen et al. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO guideline J Urol 190 2013 441 449
7. B.J. Trock, M. Han, and S.J. Freedland et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JAMA 299 2008 2760 2769
8. A.J. Stephenson, S.F. Shariat, and M.J. Zelefsky et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 2004 1325 1332
9. A.J. Stephenson, P.T. Scardino, and M.W. Kattan et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2007 2035 2041
10. S.E. Cotter, M.H. Chen, and J.W. Moul et al. Salvage radiation in men after prostate-specific antigen failure and the risk of death Cancer 117 2011 3925 3932
11. T. Wiegel, G. Lohm, and D. Bottke et al. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome - results of a retrospective study Int J Radiat Oncol Biol Phys 73 2009 1009 1016
12. J.D. Karlin, B.F. Koontz, and S.J. Freedland et al. Identifying appropriate patients for early salvage radiotherapy after prostatectomy J Urol 190 2013 1410 1415
13. H. Geinitz, M.G. Riegel, and R. Thamm et al. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy Int J Radiat Oncol Biol Phys 82 2012 1930 1937
14. A. Goenka, J.M. Magsanoc, and X. Pei et al. Long-term outcomes after high-dose postprostatectomy salvage radiation treatment Int J Radiat Oncol Biol Phys 84 2012 112 118
15. A. Siegmann, D. Bottke, and J. Faehndrich et al. Salvage radiotherapy after prostatectomy - what is the best time to treat? Radiother Oncol 103 2012 239 243
16. S. Hayashi, K. Hayashi, and R. Yoshimura et al. Salvage radiotherapy after radical prostatectomy: outcomes and prognostic factors especially focusing on pathological findings J Radiat Res 53 2012 727 734
17. M.S. Katz, M.J. Zelefsky, and E.S. Venkatraman et al. Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer J Clin Oncol 21 2003 483 489
18. D. Pfister, M. Bolla, and A. Briganti et al. Early salvage radiotherapy following radical prostatectomy Eur Urol 65 2014 1034 1043
19. J.J. Fütterer Imaging of recurrent prostate cancer Radiol Clin North Am 50 2012 1075 1083
20. J. Mohler, R.R. Bahnson, and B. Boston et al. NCCN clinical practice guidelines in oncology: prostate cancer J Natl Compr Canc Netw 8 2010 162 200
21. F.E. Harrell Jr., R.M. Califf, and D.B. Pryor et al. Evaluating the yield of medical tests JAMA 247 1982 2543 2546
22. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
23. A.J. Vickers, and E.B. Elkin Decision curve analysis: a novel method for evaluating prediction models Med Decis Making 26 2006 565 574
24. M.C. Mir, J. Li, J.C. Klink, M.W. Kattan, E.A. Klein, and A.J. Stephenson Optimal definition of biochemical recurrence after radical prostatectomy depends on pathologic risk factors: identifying candidates for early salvage therapy Eur Urol 66 2014 204 210
25. D. Moghanaki, B.F. Koontz, and J.D. Karlin et al. Elective irradiation of pelvic lymph nodes during postprostatectomy salvage radiotherapy Cancer 119 2013 52 60
26. D.E. Soto, N.M. Passarelli, and S. Daignault et al. Concurrent androgen deprivation therapy during salvage prostate radiotherapy improves treatment outcomes in high-risk patients Int J Radiat Oncol Biol Phys 82 2012 1227 1232
27. B.W. Corn, K. Winter, and M.V. Pilepich Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group Urology 54 1999 495 502
28. R. Tiguert, J. Rigaud, and L. Lacombe et al. Neoadjuvant hormone therapy before salvage radiotherapy for an increasing post-radical prostatectomy serum prostate specific antigen level J Urol 170 2003 447 450
29. F. Abdollah, S. Boorjian, and C. Cozzarini et al. Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: the impact of competing causes of mortality and patient stratification Eur Urol 64 2013 557 564
30. W.C. Jackson, S.B. Johnson, and D. Li et al. A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy Radiat Oncol 8 2013 170
31. K.C. Cary, C.S. Johnson, and L. Cheng et al. A critical assessment of post-prostatectomy prostate specific antigen doubling time acceleration - is it stable? J Urol 187 2012 1614 1619
32. J.R. Bernard Jr., S.J. Buskirk, and M.G. Heckman et al. Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis Int J Radiat Oncol Biol Phys 76 2010 735 740